---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-036223"
form_type: "8-K"
ticker: "SHPH"
cik: "0001757499"
company_name: "Shuttle Pharmaceuticals Holdings, Inc."
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T04:57:57.930738+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Shuttle Pharma receives Nasdaq delisting notice for low equity ($801K vs $2.5M)

## Summary
- Nasdaq notified Shuttle Pharma on Sept 10, 2024 of non-compliance with minimum stockholders' equity of $2.5M; reported equity $801,434.
- Company has 45 days (until Oct 25, 2024) to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension.
- Non-compliance has no immediate effect on listing; if plan rejected or not met, securities could be delisted with appeal rights.
- Company is evaluating actions to regain compliance but no assurance of success.

## SEC filing metadata
- accession: 0001493152-24-036223
- form_type: 8-K
- ticker: SHPH
- cik: 0001757499
- company_name: Shuttle Pharmaceuticals Holdings, Inc.
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757499/000149315224036223/0001493152-24-036223-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757499/000149315224036223/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-036223
- JSON: https://secwatch.observer/filing/0001493152-24-036223.json
- Plain text: https://secwatch.observer/filing/0001493152-24-036223.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.